Search

MYR-101

ASPA is produced in oligodendrocytes, and participates in the metabolism of N-acetylaspartate (NAA). … Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain.

Mycobacterium w. Vaccine

As an immunotherapy, M.w is used against leprosy; the compound also shares antigens with M. tuberculosis. … M.w immunization activates macrophages and lymphocytes upon administration. It has protective efficacy against M. tuberculosis and M. leprae.

CDX-6512

CDX-6512 is a modified, gastrointestinal-stable bacterial leucine decarboxylase. Developed by Codexis, it is being investigated for the treatment of homocystinuria And Maple Syrup Urine Disease.

AP5346

It is being pursued by Access Pharmaceuticals, Inc. … AP5346 is designed to target a diaminocyclohexane platinum (Pt) moiety to tumors through pH-sensitive linkage to a 25 kDa hydroxypropylmethacrylamide polymer.

EHC18

EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.

TG-C

Elinogrel

A P2Y12 inhibitor and platelet aggregation inhibitor.

Dipropyl-4-hydroxytryptamine

Dipropyl-4-hydroxytryptamine is the 4-hydroxyl analog of dipropyltryptamine (DPT). Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. … This agent and its properties haven't been fully elucidated.

Fasedienol

PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder). … It is a member of a new family of pharmaceutical compounds called vomeropherins.

Pyrazoloacridine

Pyrazoloacridine has been used in trials studying the treatment of Lung Cancer, Liver Cancer, Breast Cancer, Melanoma (Skin), and Metastatic Cancer, among others.